Scientific and professional experiences

• Ph.D. in Pharmacology & Toxicology from University of Georgia, USA (GPA: 3.73 out of 4:00).

  1995

• Assistant Professor (1996-2001), Associate Professor (2001-2006) then Professor (2006-present) of Pharmacology & Toxicology, Faculty of Pharmacy, Ain Shams University (ASU), Cairo, Egypt.

• Adjunct Assistant/Associate Professor at the American University in Cairo (AUC)

  1996 - 2004

• Member of the National Committee responsible for monitoring & assessing the achievements of 157 quality assurance and accreditation projects (QAAP) financed by the World Bank and implemented under supervision of European QA consultants in Egyptian Public Universities under the governance of the Ministry of Higher Education (MOHE)

  2005 - 2009

• Principle Investigator of QAAP & Manager of QA Unit, in Faculty of Pharmacy at ASU

  2006 - 2007

• Head of Pharmacology & Toxicology Department, Faculty of Pharmacy, ASU

  2006 - 2010

• Director of Quality Assurance & Qualifying for Accreditation Center (QAQAC), ASU

  2007 - 2012

• Certified Trainer, The National Center for Faculty and Leadership Development, MOHE

  2008

• Certified Trainer, The School of Continuing Education, AUC

  2008

• Member of the national committee evaluating the status of HE in Egypt in collaboration with experts from the World Bank and Organization for Economic Cooperation & Development (OECD) and the author of “Quality of Higher Education” chapter in the last "Egypt Background Report"

  2009

• Quality Assurance Consultant, Strategic Planning Unit, MOHE

  2008 - 2011

• Member of the national committee reviewing the strategic plan of MOHE

  2010

• Member of the National Steering Committee managing all higher education development projects (PCIQA), MOHE

  2010 - 2011

• Vice-Dean for Graduate Studies and Research, Faculty of Pharmacy, ASU

  2010 - 2013

• Acting Dean of Faculty of Pharmacy, ASU for several periods while being the Vice-Dean for Graduate Studies

• Certified Reviewer / Chair, The National Authority for Quality Assurance and Accreditation of Education then the European Quality Assurance Agency

  2010- present

• Representative of MOHE in “The International Network for Quality Assurance Agencies in Higher Education (INQAAHE) Conference” in Spain

  April 2011

• Representative of ASU in “The First Conference of the Arab Network for Quality Assurance in Higher Education (ANQAHE), held in UAE

  Dec 2011

• Prepared a comprehensive strategic plan for development of ASU before the election of a new ASU President in Nov 2011. Was among the final nominees ranked 6th out of 18 candidates

  Nov 2011

• Representative of MOHE in the first workshop organized by UNESCO to discuss “Quality Assurance of Higher Education Systems in the Arab States” in Sudan

  Nov 2013

• Board Member, "The National Holding Company for Biological Products & Vaccines"

  2012 and 2014-2015

• Advisor and Board Member of QAQAC, ASU

  2012-2014

• Board Member, Children Cancer Hospital in Egypt 57357 (CCHE 57357)

  2012-2014

• Advisor to the Chairman of "The National Holding Company for Biological Products and Vaccines" for Strategic Planning

  2013

• Member of "The National Committee for Promoting Associate Professors& Full Professors in the Field of Pharmacology and Clinical Pharmacy", Supreme Council of Universities, MOHE

  2013-2016

• Member of the National Specialized Councils for Health Services

  2013-2015

• Certified Board Member, “The Egyptian Financial Supervisory Authority”

  2014

• Representative of MOHE in the Scientific Research Committee, Federation of Egyptian Industries

  2014 - 2016

• Advisor to the Chairman of CCHE 57357 for Strategic Planning

  2014 - 2016

• Member of the Supreme Council for Technical Colleges, MOHE

  2015- 2016

• Member of "The National Committee for Pharmacology", Academy of Scientific Research & Technology, MOHE

  2014 - 2018

• Member of "The National Committee for Preparing “Science, Technology & Innovation Law”, MOHE

  2016

• The Scientific Consultant of CCHE 57357 Hospital Group for Pharmacy Affairs

  2016- 2021

• External Reviewer, Supreme Council of Private Universities, MOHE

  2016- present

• International Academic Quality Assurance Expert participated in reviewing accreditation standards and in developing a new ranking system for universities worldwide in collaboration with international specialized organizations

  2017-present

• Representative of the Minister of Higher Education in some private universities.

  2019- Present

• Advisor to the President of Ain Shams University for the Project of the New Non-Profit Ain Shams University

  March 2021-Present

• نشر 74 بحث في مجال تخصص علم الأدوية والسموم والصيدلة الإكينيكية، الغالبية بحوث منشورة دولياً كما يلي:

  1. Khalifa AE and Ghoneim AI. Plausible Pharmacological Interpretation of Hydroxychloroquine Ineffectiveness for Treatment of COVID-19 in Hospitalized Patients. Archives of Pharmacy & Pharmacology Research 2021. In proof reading stage.
  2. Khalifa AE and Ghoneim AI. Ongoing COVID-19 Clinical Trials: A Pharmacological Perspective on Pneumonia. Current Trends in Clinical & Medical Sciences 2020. https://irispublishers.com/ctcms/pdf/CTCMS.MS.ID.000533.pdf. In proof reading stage.
  3. Elmaaty MA, Elberry AA, Hussein RR, Khalil DM, Khalifa AE. Applicability of American College of Clinical Pharmacy (ACCP) competencies to clinical pharmacy practice in Egypt. Pharmacy Practice 2020. https://doi.org/10.18549/PharmPract.2020.3.1951.
  4. Nagib MM, Tadros MG, Rahmo RM, Sabri NA, Khalifa AE, Masoud SI. Ameliorative Effects of α-Tocopherol and/or Coenzyme Q10 on Phenytoin-Induced Cognitive Impairment in Rats: Role of VEGF and BDNF-TrkB-CREB Pathway. Neurotox Res 2019; 35, 451–462.
  5. Khalifa AE. Defining fingerprint pattern of cardiotoxicity and targeting specific underlying mechanisms of cardiotoxicity could be the way for successful cardioprotective measures in pediatric cancer patients treated with anthracyclines. Advances in Cancer Research and Clinical Imaging 1(2): 2018. ACRCI.MS.ID.000506. DOI: 10.33552/ACRCI.2018.01.000506.
  6. Elsayed AA, Menze ET, Tadros MG, Ibrahim BMM, Sabri NA, Khalifa AE. Effects of genistein on pentylenetetrazole- induced behavioral and neurochemical deficits in ovariectomized rats. Naunyn Schmiedebergs Archives of Pharmacology 2018; 391: 27–36.
  7. Khalifa AE. Complementary and Alternative Medicine Use in Cancer: The Role of Clinical Pharmacists. Advances in Cancer Research and Clinical Imaging 1(1): 2018. ACRCI.MS.ID.000502. DOI: 10.33552/ACRCI.2018.01.000502.
  8. Salama RM, Tadros MG, Shaalan MF, Bahaa N, Abdel-tawab AM, Khalifa AE. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model. Journal of Cellular Physiology 2018; 233:5981–6000. DOI: 10.1002/jcp.26412.
  9. Khalifa AE. Hypothyroidism, Hypertension and Breast Cancer: Scientific Insights. Advances in Cancer Research and Clinical Imaging 1(1): 2018. ACRCI.MS.ID.000501. DOI:10.33552/ACRCI.2018.01.000501.
  10. Allam RM, Al-Abd AM, Khedr A, Sharaf QA, Nofal SM, Khalifa AE, Mosli HA, Abdel-Naim AB. Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. Toxicology Letters 2018; 291:77-85.
  11.Nagib mM, Tadros MG, AbdAl-khalek HA, Rahmoa RM, Sabri NA, Khalifa AE, Masoud SI. Molecular mechanisms of neuroprotective effect of adjuvant therapy with phenytoin in pentylenetetrazole-induced seizures: Impact on Sirt1/NRF2 signaling pathways. NeuroToxicology 2018, 68:47-65.
  12.Shoieb SM, Esmat A, Khalifa AE, Abdel-Naim AB. Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats. Food Chemistry & Toxicology 2017; 111: 690-659.
  13.Salama RM, Tadros MG, Schaalan MF, Bahaa N, Abdel-tawab MA, Khalifa AE. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model. Journal of Cellular Physiology 2017; 1–20.
  14.Wahdan SA, Tadros MG, Khalifa AE. Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats. Naunyn Schmiedebergs Archives of Pharmacology 2017; 390: 905-917.
  15.Michel HE, Tadros MG, Esmat A, Khalifa AE, Abdel-Tawab AM. Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions. Molecular Neurobiology 2017; 54:4866-4878.
  16.Menze ET, Esmat A, Tadros MG, Khalifa AE, Abdel-Naim AB. Genistein improves sensorimotor gating: Mechanisms related to its neuroprotective effects on the striatum. Neuropharmacology 2016; 105:35-46.
  17.Youssef MM;  Tolba MF; Badawy NN; Liu AW; El-Ahwany E; Khalifa AE; Zada S, Abdel-Naima AB. Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells. Scientific Reports 2016; 6: 30717.
  18.Tolba MF, Omar HA, Azab SS, Khalifa AE, Abdel-Naim AB, Abdel-Rahman SZ. Caffeic Acid Phenethyl Ester: A Review of Its Antioxidant Activity, Protective Effects against Ischemia-reperfusion Injury and Drug Adverse Reactions. Critical Reviews in Food Science and Nutrition 2016 56:13, 2183-2190, DOI: 10.1080/10408398.2013.821967.
  19.El-Hawary EA, Abdel-Aziz E, Labib RM, Esmat A, Abdel-Naim AB, Khalifa AE, Singab AN, Ayoub NA. Anti-inflammatory Activity of the Phenolic-rich Extract of Schotia brachypetalea Sond. Fam. Fabaceae, Cultivated in Egypt. European Journal of Medicinal Plants 2015; 8: 190-201.
  20.Habib CN, Al-Abd AM, Tolba MF, Khalifa AE, Khedr A, Mosli HA, Abdel-Naim AB. Leptin influences estrogen metabolism and accelerates prostate cell proliferation. Life Sciences, 2015; 121: 10–15.
  21.Abdel-Latif GA, Al-Abd AM, Tadros MG, Al-Abbasi FA, Khalifa AE, Abdel-Naim AB. The chemomodulatory effects of resveratrol and didox on Herceptin cytotoxicity in breast cancer cell lines. Scientific Reports 2015; 5:12054.
  22.Hanna DMF, Tadros MG, Khalifa AE. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2015; 60: 36–51.
  23.Menze ET, Esmat A, Tadros MG, Abdel-Naim AB, Khalifa AE. Genistein Improves 3-NPA-Induced Memory Impairment in Ovariectomized Rats: Impact of Its Antioxidant, Anti-Inflammatory and Acetylcholinesterase Modulatory Properties. PloS ONE 2015; 10:1-21.
  24.Al-Abd AM, Fahad A. Al-Abbasi FA, Nofal SM, Khalifa AE, Williams RO, El-Eraky WI, Nagy AA, Abdel-Naim AB. Nimesulide Improves the Symptomatic and Disease Modifying Effects of Leflunomide in Collagen Induced Arthritis. PloS ONE 2014; 9:1-8.
  25.Tolba MF, Omar HA, Azab SS, Khalifa AE, Abdel-Naim AB, Abdel-Rahman SZ. Caffeic acid phenethyl ester: A review of its antioxidant activity, protective effects against ischemia-reperfusion injury and drug adverse reactions. Food Science and Nutrition 2014; 56: 2183-2190.
  26.Mahmoud MA, Galal AF, Ghoneim AI, Khalifa AE, Elshabrawy OA. Exercise Prevents Cardiovascular Dysfunction by Suppression of some Pro-Inflammatory Cytokines. Current Science International 2014; 3: 2077-4435.
  27.Atawia RT, Mosli HH, Tadros MG, Khalifa AE, Mosli HA, Abdel-Naim AB. Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB. Naunyn-Schmiedeberg's Archives of Pharmacology 2014; 387:1131–1140.
  28.Mahdy HM, Mohamed MR, Emam MA, Karim AM, Abdel-Naim AB, Khalifa AE. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. Canadian Journal of Physiology & Pharmacology 2014; 92:252-258.
  29.Mahdy HM, Mohamed MR, Emam MA, Karim AM, Abdel-Naim AB, Khalifa AE. Puerarin Ameliorates 3-Nitropropionic Acid-Induced Neurotoxicity in Rats: Possible Neuromodulation & Antioxidant Mechanisms. Neurochemical Research 2014; 39:321–332.
  30.Abdellateef SM, Abdelmageed WM, AlTaher WM, Khalifa AE. Hormonal and metabolic responses of controlled hypotensive anesthesia for functional endoscopic sinus surgery: A comparison between magnesium sulfate and nitroglycerine. Egyptian Journal of Intensive Care and Trauma 2013; 3: 79-89.
  31.Nagib MM, Tadros MG, ELSayed MI, Khalifa AE. Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats. Toxicology and Applied Pharmacology 2013; 271: 106–113.
  32.Allam RM, Selim DA, Ghoneim AI, Radwan MM, Nofal SM, Khalifa AE, Sharaf OA, Toaima SM, Asaad AM, El-Sebakhy NA. Hepatoprotective effects of Astragalus kahiricus root extract against ethanol-induced liver apoptosis in rats. Chinese Journal of Natural Medicines 2013; 11: 0354−0361.
  33.Tolba MF, Azab SS, Khalifa AE, Abdel-Rahman SZ, Abdel-Naim AB. Caffeic Acid Phenethyl Ester, a Promising Component of Propolis with a Plethora of Biological Activities: A Review on its Anti-inflammatory, Neuroprotective, Hepatoprotective, and Cardioprotective Effects. International Union of Biochemistry and Molecular Biology 2013; 65: 699–709.
  34.Tolba MF, Esmat A, Al-Abd AM, Azab SS, Khalifa AE, Mosli HA, Abdel-Rahman SZ, Abdel-Naim AB. Caffeic Acid Phenethyl Ester Synergistically Enhances Docetaxel and Paclitaxel Cytotoxicity in Prostate Cancer Cells. International Union of Biochemistry and Molecular Biology, 2013; 65: 716–729.
  35.Salama RM, Schaalan MF, Elkousssi AA, Khalifa AE. Potential Utility of Sodium Selenate as an Adjunct to Metformin in Treating Type II Diabetes Mellitus in Rats: A Perspective on Protein Tyrosine Phosphatase. BioMed Research International 2013; 1:1-9.
  36.Salama RM, Schaalan MF, Ibrahim ME, Khalifa AE, Elkousssi AA. Effectiveness of Telmisartan as an Adjunct to Metformin in Treating Type II Diabetes Mellitus in Rats. Open Journal of Endocrine and Metabolic Diseases 2013; 3: 186-196.
  37.Atawia RT, Tadros MG, Khalifa AE, Mosli HA, Abdel-Naim AB. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats. Toxicology Letters 2013; 219:160- 169.
  38.Abd-Elhady RM, Elsheikh AM, Khalifa AE. Anti-amnestic properties of Ginkgo biloba extract on impairedmemory function induced by aluminum in rats. International Journal of Developmental Neuroscience 2013; 31:598–607.
  39.Michel HE, Tadros MG, Abdel-Naim AB, Khalifa AE. Prepulse inhibition (PPI) disrupting effects of Glycyrrhiza glabra extract in mice: a possible role of monoamines. Neurosci Letters 2013; 544:110-114.
  40.Menze ET, MG Tadros, Abdel-Tawab AM, Khalifa AE. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. NeuroToxicology 2012; 33:1265–1275.
  41.Esmat A, Ghoneim AI, El-Demerdash E, Khalifa AE, Abdel-Naim AB. Dichloroacetonitrile induces oxidative stress and developmental apoptotic imbalance in mouse fetal brain. Environmental Toxicology and Pharmacology 2012; 33: 78-84.
  42.Salama RM, Schaalan MF, Ibrahim ME, Khalifa AE, Elkousssi AA. Telmisartan improves insulin resistance as an adjunct to metformin in high fat high fructose diabetic rats. European Review for Medical and Pharmacological Sciences 2012; 20: 202-208.
  43.Khalifa AE, Ibrahim DK, Al-Shatoury HA, Shaaban IG, EL-Gizawy AM, Eltalawy HA, Youssef TF, Radwan MM, Abdellah GA. Quality assurance processes in Egyptian higher education institutions at both institutional and national level: Their development and sustainability. The International Network for Quality Assurance Agencies in Higher Education (INQAAHE) Conference Bulletin. Madrid, 4-7th of April, 2011.
  44.Mahran YY, Khalifa AE, El-Demerdash E. A comparative study of protective mechanisms of glycine and L-arginine against cisplatin-induced nephrotoxicity in rat renal cortical slices. Drug Discoveries &Therapeutics 2011; 5: 32-40.
  45.Mahdy HM, Tadros MG, Mohamed MR, Karim AM, Khalifa AE. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Neurochemistry International 2011; 59: 770–778.
  46.Al-Abd AM, Inglis JJ, Nofal SM, Khalifa AE, Williams RO, El-Eraky WI, Abdel-Naim AB. Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis. European Journal of Pharmacology 2010; 644: 245-250.
  47.Badr AM, El-Demerdash E, Khalifa AE, Ghoneim AI, Ayoub NA, Abdel-Naim AB. Rubus sanctus protects against carbon tetrachloride-induced toxicity in rat isolated hepatocytes: Isolation and characterization of its galloylated flavonoids. Journal of Pharmacy and Pharmacology 2009; 61: 1511–1520.
  48.Azab SS, Salama SA, Abdel-Naim AB, Khalifa AE, El-Demerdash E, Al-Hendy A. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells? Breast Cancer Research and Treatment 2009; 113: 9-19.
  49.Nasralla SN, Ghoneim AI, Khalifa AE, Gad MZ, Abdel-Naim AB. Lactoperoxidase catalyzes in vitro activation of acrylonitrile to cyanide. Toxicology Letters 2009; 191: 347–352.
  50.Tadros MG, Mohammad MR, Yossif AM, Sabry GM, Khalifa AE. Pro-apoptotic and pre-pulse inhibition (PPI) disrupting effect of Hypericum Perforatum in rats. Journal of Ethnopharmaology 2009; 122: 561-566.
  51.Tadrosa MG, Mohamed MR, Youssef AM, Sabry GM, Sabry NA, Khalifa AE. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John’s wort-induced prepulse inhibition deficit: A possible role of hyperforin. Behavioral Brain Research 2009; 199: 334–339.
  52.Azab SS, Salama SA, Hassan MH, Khalifa AE, El-Demerdash E, Fouad H, Al-Hendy A, Abdel-Naim AB. 2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft. Cancer Chemotherapy and Pharmacology 2008; 62: 893-902.
  53.Ezat R, Selim AA, Abdel-salam OM, Ismail MA, Khalifa AE. Pharmacological studies on the ischemic rat lower limb using Laser Doppler blood flowmetry. Immunopharmacology 2008; 16:145–150.
  54.Mostafa RE, Sleem AA, Abdel-Salam OME, Ismail MA, and Khalifa AE. A Laser doppler study of the effect of 2-alkylthio-4-ethyl-4-methyl-4,5 dihydro-1H-imidazolin-5-one oxime (oxime) on the ischaemic rat lower limb. Inflammopharmacol 2008, 16:145–150.
  55.Khalifa AE. Anti-infective Agents Affecting Cognition: A Review. Journal of Chemotherapy 2007; 19: 620-631.
  56.El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary ES. Reversal of scopolamine-induced amnesia in rats by the neuroleptic zuclopenthixol: Underlying monoaminergic and cholinergic mechanisms. The New Egyptian Journal of Medicine 2006; 35: 137-146.
  57.Habashy RR, Abdel-Naim AB, Khalifa AE, El-Azizi MM. Anti-inflammatory effects of jojoba liquid wax in experimental models. Pharmacological Research, 2005; 51: 95-105.
  58.Khalifa AE. Neural monoaminergic mediation of the effect of St. John’s wort extract on prepulse inhibition of the acoustic startle response in rats. Journal of Psychopharmacology 2005; 19:467–472.
  59.Khalifa A.E. Effect of cefepime on startle amplitude and prepulse inhibition of startle reflex in rats: Manipulation of GABA-A receptor function with midazolam. Methods and Findings in Experimental and Clinical Pharmacology 2005; 27: 639-644.
  60.Tadros MG, Khalifa AE, Abdel-Naim AB, Arafa HM. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington’s disease phenotype. Pharmacology Biochemistry and Behavior 2005; 82: 574-82.
  61.Khalifa AE. Pro-oxidant activity of zuclopenthixol in-vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats. Human & Experimental Toxicology 2004; 23: 439- 445.
  62.Khalifa AE. Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanism. Pharmacology, Biochemistry and Behavior 2003; 75: 755–762.
  63.El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary ES. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacology Biochemistry and Behavior 2003; 76: 525-533.
  64.Khalifa AE, Moustafa YM, Mahran LG, Eldenshary ES. DL-alpha-lipoic acid demonstrates hepatoprotective properties in liver toxicity induced by acute carbon tetrachloride administration in rats. The New Egyptian Journal of medicine 2003; 29: 80-88.
  65.Abdel-Naim AB, Khalifa AE, Ahmed SH. Protective effects of garlic oil against liver damage induced by combined administration of ethanol and carbon tetrachloride in rats. The Egyptian Journal of Hospital Medicine 2002; 6: 27-36.
  66.Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES. Protective effects of curcumin against ischemia/reperfusion insult in rat forebrain. Pharmacological Research 2002; 64: 321-327.
  67.Khalifa AE. Hypericum Perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. Journal of Ethnopharmacology 2001; 76:49-57.
  68.Abd El-Gawad HM and Khalifa AE. Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain. Pharmacological Research 2001; 43: 257-263.
  69.Khalifa A.E. Antiamnestic properties of [-]-Hydrastine: Modulation of benzodiazepine-induced anterograde amnesia of inhibitory avoidance task in mice. Ain Shams Medical Journal 2000; 51: 405-419.
  70.Ismail MA, Abouzid K, Farag AE, Khalifa AE. Synthesis and evaluation for potential antihypertensive activity of a series of substituted imidazolinone oximes and cyclohexanespiro-8-imidazo[5,1-c]-1,2,4-oxadiazines. Alexandria Journal of Pharmaceutical Sciences 2000; 14: 151-161.
  71.Badary OA, Abdel-Naim AB, Khalifa AE, Hamada FM. Differential alteration of cisplatin cytotoxicity and myelotoxicity by the paclitaxel vehicle cremophor EL. Naunyn-Schmiedebergs Archives of Pharmacology 2000; 361, 339-344.
  72.Sayed-Ahmed MM, Khattab MM, Khalifa AE, El-Kabany MA, Osman AM. Potential promise of using L-carnitine and coenzyme Q10 as protective agents against cisplatin-induced nephrotoxicity”. Journal of the Egyptian National Cancer Institute-Cairo University 1999; 11: 167-173.
  73.Seif-El-Nasr M, Mahran LG, Al-Abhar HS, Khalifa AE, El-Denshary ES. Possible neuroprotective effects of melatonin against ischaemia/reperfusion insult in rat brain. Medical Science Research 1999; 27, 605-608.
  74.Ramshur S, Khalifa AE, Iturrian WB. Does paroxysmal dystonia have a sensory/anxiety disorder etiology? Conference Bulletin of the “Southern Meeting of the American Association of Pharmaceutical Scientists, University of Mississippi” 1998; 1: 211-225.
  75.Khalifa AE, Abdel-Saboor J, El-Denshary ESM. Tocolytic effect of melatonin: Possible modification of uterine response to certain drugs by pre-treatment with melatonin in non-pregnant rats. Bulletin of Faculty of Pharmacy of Cairo University 1997; 35: 233-237.